Can you take peptides Peptide drugs represent a significant and rapidly evolving class of therapeutics, offering targeted treatments for a wide array of diseases.Therapeutic Peptides: Recent Advances in Discovery ... These molecules, composed of short chains of amino acids, leverage the body's natural signaling pathways to exert their effects. Among the most well-known peptide drugs are those used for diabetes and obesity management, such as semaglutide (marketed as Ozempic and Wegovy) and tirzepatide, which have revolutionized treatment paradigms.From injections to pills: oral peptides set to transform drug ... The diverse applications of peptide therapeutics span from managing chronic conditions to treating cancers and infections, underscoring their growing importance in modern medicine.
The landscape of peptide drugs is rich with examples across various therapeutic areas. A foundational example is human insulin, a critical treatment for diabetes that paved the way for many subsequent peptide therapies. Similarly, growth hormone has been a long-standing therapeutic peptide.
More recent advancements have seen significant success in metabolic diseases. Glucagon-like peptide-1 (GLP-1) analogs, including liraglutide and semaglutide, are prime examples, effectively managing type 2 diabetes and aiding in weight loss. These drugs mimic natural hormones to regulate blood sugar and appetite.
In the realm of oncology, peptide drugs like leuprolide acetate (Lupron) and zoladex are used to treat hormone-sensitive cancers, such as prostate and breast cancer, by modulating hormone production.作者：B Zheng·2025·被引用次数：28—Insulin, isolated in 1921, remains a landmark example, revolutionizing diabetes care. However, shorter peptides such as oxytocin, vasopressin, and somatostatin ... Another notable example is Lutetium-177-DOTATATE (Lutathera), a peptide-based drug for treating neuroendocrine tumors.
Osteoporosis management also benefits from peptide therapeutics2022年7月29日—Among the marketed peptide drugs, there are several drugs with annual sales of over billion, such asinsulin, glatiramer acetate, liraglutide.... Abaloparatide is utilized for this condition, targeting bone metabolism. Calcitonin is another peptide used in osteoporosis treatment2025年8月12日—For example,orally bioavailable PCSK9 inhibitor, Enlicitide(MK-0616), is currently in Phase III trials for treatment of adult ....
Beyond these major categories, peptide drugs are also explored for their antimicrobial properties, acting as a defense mechanism against infections.2022年7月29日—Among the marketed peptide drugs, there are several drugs with annual sales of over billion, such asinsulin, glatiramer acetate, liraglutide... Research is also advancing in peptide vaccines and carriers, as well as peptide-drug conjugates (PDCs), highlighting the broad potential of this therapeutic modality.2022年7月29日—Among the marketed peptide drugs, there are several drugs with annual sales of over billion, such asinsulin, glatiramer acetate, liraglutide...
The development of peptide drugs has seen remarkable progress, moving beyond traditional injectable formulations. While many peptide therapeutics remain injectables due to challenges with oral bioavailability, there is a significant push towards developing oral peptide drugs2022年7月29日—Among the marketed peptide drugs, there are several drugs with annual sales of over billion, such asinsulin, glatiramer acetate, liraglutide.... For instance, orally bioavailable PCSK9 inhibitors like Enlicitide are in late-stage clinical trials. This innovation aims to improve patient convenience and adherence.作者：L Wang·2022·被引用次数：2170—Human insulin and growth hormoneare representative examples of the many available peptide drugs made using recombinant DNA technology.
The therapeutic potential of peptides is continually being unlocked作者：B Zheng·2025·被引用次数：28—Insulin, isolated in 1921, remains a landmark example, revolutionizing diabetes care. However, shorter peptides such as oxytocin, vasopressin, and somatostatin .... From naturally occurring hormones like oxytocin and vasopressin to complex synthetic molecules, researchers are exploring peptides for a wide range of applications. This includes developing peptide-based treatments for cardiovascular diseases, neurological disorders, and autoimmune conditions.List of Marketed Peptide Drugs The inherent specificity and lower toxicity profiles of many peptides make them attractive candidates for targeted therapies.
Despite their promise, peptide drugs face challenges, including their susceptibility to enzymatic degradation, short half-lives, and delivery issues. However, ongoing research in chemical modifications, such as lipidation (as seen with liraglutide), and the development of novel delivery systems are actively addressing these limitations. The increasing understanding of peptide biology and advancements in drug discovery technologies are paving the way for a new generation of peptide therapeutics that could further transform healthcare.
Join the newsletter to receive news, updates, new products and freebies in your inbox.